mRNA-1345

Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
BioSpace
Mon, 01/30/23 - 10:37 am
Moderna Therapeutics
FDA
mRNA-1345
vaccines
RSV
breakthrough therapy
Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot
Fierce Biotech
Wed, 04/14/21 - 09:38 am
Moderna Therapeutics
vaccines
mRNA-1345
RSV
COVID-19